Bob Macel

Title: Bob Macel: Innovator in Pharmaceutical Chemistry

Introduction

Bob Macel is a notable inventor based in Thornhill, CA. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on sulfoxide-carboxylate intermediates of omeprazole and lansoprazole. His research has implications for the development of important medications.

Latest Patents

Bob Macel holds 1 patent for his invention titled "Sulfoxide-carboxylate intermediates of omeprazole and lansoprazole." This patent details a process for producing omeprazole and lansoprazole, which are chemically classified as pyridine-benzimidazole sulfinyl compounds. The process involves the oxidation of acetamide-sulfide compounds to form the amide sulfinyl compound, followed by alkaline hydrolysis to yield the sulfinyl carboxylate or salt, and concludes with decarboxylation.

Career Highlights

Throughout his career, Bob Macel has demonstrated a commitment to advancing pharmaceutical research. His work has not only contributed to the understanding of sulfinyl compounds but has also paved the way for the development of effective treatments for various medical conditions.

Collaborations

Bob has collaborated with Clarke Slemon, a fellow researcher, to further explore the applications of his patented processes. Their partnership has fostered a productive environment for innovation in pharmaceutical chemistry.

Conclusion

Bob Macel's contributions to the field of pharmaceutical chemistry, particularly through his patent on sulfoxide-carboxylate intermediates, highlight his role as an innovator. His work continues to influence the development of important medications.